NUVL — Nuvalent Income Statement
0.000.00%
Last trade - 00:00
- $4.28bn
- $3.56bn
- 38
- 26
- 92
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 10.4 | 16.9 | 45.8 | 86.1 | 149 |
Operating Profit | -10.4 | -16.9 | -45.8 | -86.1 | -149 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.8 | -14.6 | -46.3 | -81.9 | -126 |
Net Income After Taxes | -11.8 | -14.6 | -46.3 | -81.9 | -126 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.8 | -14.6 | -46.3 | -81.9 | -126 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.8 | -14.6 | -46.3 | -81.9 | -126 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.252 | -0.311 | -0.959 | -1.65 | -2.17 |